1 hour ago
Eli Lilly (LLY) Acquires Psychedelic Drug Developer AtaiBeckley in $2.8B Deal
Eli Lilly (LLY) stock announces $2.8B acquisition of AtaiBeckley to gain access to experimental DMT nasal spray for treatment-resistant depression.
The post Eli Lilly (LLY) Acquires Psychedelic Drug Developer AtaiBeckley in $2.8B Deal appeared first on Blockonomi.
Source: Blockonomi →Related News
- 25 minutes ago
J.B. Hunt (JBHT) Stock Surges 7% Following Strong Q2 Earnings Beat
- 26 minutes ago
Eli Lilly Acquires AtaiBeckley (ATAI) for $2.8B, Stock Jumps 34%
- 38 minutes ago
ARK Invest Loads Up on SpaceX Shares Before Critical Starship Mission
- 39 minutes ago
Micron (MU) Stock Plunges 12% as Multiple Headwinds Converge
- 53 minutes ago
Merck (MRK) Stock Climbs After FDA Greenlight for Revolutionary Cholesterol Medi...